About this trial
The purpose of this registry aims is to collect a large number of patients with mild and moderate asthma in a real-word conditions for a perspective observation of epidemiological evolution of the disease in relation to the therapeutic interventions available currently and in the near future.
Eligibility criteria
Qualifiers
Adult patients
Asthma diagnosis according GINA 2020 algorithm (Annex 1)
Patients enrolled in other previous or ongoing observational studies
Disqualifiers
Severe asthma patients according International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. [Chung KF et al. European Respiratory Journal Feb 2014, 43 (2) 343-373; DOI: 10.1183/09031936.00202013 (Annex 2)]
Subjects are excluded from this cohort if they exhibit interstitial lung diseases, pulmonary neoplasms, current lung infections, immunological disorders leading to the use of immunosuppressants or continuous treatment with oral steroids.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Societa Italiana di Pneumologia
Lead sponsor
Società Italiana di Allergologia, Asma e Immunologia Clinica
Collaborator